» Articles » PMID: 40006906

Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2025 Feb 26
PMID 40006906
Authors
Affiliations
Soon will be listed here.
Abstract

Viruses frequently exploit the host's nucleocytoplasmic trafficking machinery to facilitate their replication and evade immune defenses. By encoding specialized proteins and other components, they strategically target host nuclear transport receptors (NTRs) and nucleoporins within the spiderweb-like inner channel of the nuclear pore complex (NPC), enabling efficient access to the host nucleus. This review explores the intricate mechanisms governing the nuclear import and export of viral components, with a focus on the interplay between viral factors and host determinants that are essential for these processes. Given the pivotal role of nucleocytoplasmic shuttling in the viral life cycle, we also examine therapeutic strategies aimed at disrupting the host's nuclear transport pathways. This includes evaluating the efficacy of pharmacological inhibitors in impairing viral replication and assessing their potential as antiviral treatments. Furthermore, we emphasize the need for continued research to develop targeted therapies that leverage vulnerabilities in nucleocytoplasmic trafficking. Emerging high-resolution techniques, such as advanced imaging and computational modeling, are transforming our understanding of the dynamic interactions between viruses and the NPC. These cutting-edge tools are driving progress in identifying novel therapeutic opportunities and uncovering deeper insights into viral pathogenesis. This review highlights the importance of these advancements in paving the way for innovative antiviral strategies.

References
1.
Reid S, Valmas C, Martinez O, Sanchez F, Basler C . Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol. 2007; 81(24):13469-77. PMC: 2168840. DOI: 10.1128/JVI.01097-07. View

2.
Zaitsava H, Gachowska M, Bartoszewska E, Kmiecik A, Kulbacka J . The Potential of Nuclear Pore Complexes in Cancer Therapy. Molecules. 2024; 29(20). PMC: 11510365. DOI: 10.3390/molecules29204832. View

3.
Ikliptikawati D, Makiyama K, Hazawa M, Wong R . Unlocking the Gateway: The Spatio-Temporal Dynamics of the p53 Family Driven by the Nuclear Pores and Its Implication for the Therapeutic Approach in Cancer. Int J Mol Sci. 2024; 25(13). PMC: 11242911. DOI: 10.3390/ijms25137465. View

4.
Sharma K, Akerstrom S, Sharma A, Chow V, Teow S, Abrenica B . SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus. PLoS One. 2011; 6(5):e19436. PMC: 3103500. DOI: 10.1371/journal.pone.0019436. View

5.
Lostao A, Lim K, Pallares M, Ptak A, Marcuello C . Recent advances in sensing the inter-biomolecular interactions at the nanoscale - A comprehensive review of AFM-based force spectroscopy. Int J Biol Macromol. 2023; 238:124089. DOI: 10.1016/j.ijbiomac.2023.124089. View